Manufacturer

Galderma to open new toxin manufacturing facility

Following positive phase 2 results from its ready-to-use liquid formulation botulinum toxin, global pharmaceutical company Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden.

Read More »

On the Scene: Venus Concept event, London

Non-invasive aesthetic device manufacturer Venus Concept held an event at Chandos House in London on Monday June 10 for current and prospective customers to watch presentations, learn tips and tricks for new treatments, and to engage with other clinic owners.

Read More »